Siga las últimas noticias de la industria de la salud de los consumidores, de la farmacia, de los cosméticos, de los complementos alimenticios, de los bienes de consumo, de la venta al por mayor, de la venta al por menor y de la producción. (En inglés)
CPC es un equipo de expertos con una larga experiencia en estrategia y marketing, establecimiento de negocios internacionales, concesión de licencias, fusiones y adquisiciones, regulación, registro, publicaciones, búsqueda de ejecutivos y mucho más. (En inglés)
Los servicios de publicación de CPC son datos analíticos precisos que nos ayudan a proporcionar a nuestros clientes información esencial actualizada y conocimientos profundos sobre las tendencias de la industria farmacéutica y OTC. (En inglés)
En Chameleon Pharma Consulting somos expertos con más de 20 años de experiencia en áreas como Consumer Healthcare, Pharma Rx, Cosmética, Complementos alimenticios, FMCG, Venta al por mayor, Venta al por menor, Producción… (En inglés)
Canada’s Consumer Health Shift: What Pharmacy Chains and New Behaviors Mean for Pharma Market in 2040?
Canada’s OTC & Pharma market, valued at approx. USD 28B in 2025, is projected to reach nearly USD 61B by 2030 at a CAGR of about 6.2%, driven by expanding pharmacy chains and changing consumer health trends....
Thailand Medical Device Boom: Regulatory Strategy & Growth Opportunities to 2040
The Thailand medical device market is projected to expand from approximately USD 4.03 billion by 2030 to nearly USD 8.5 billion by 2040, reflecting an estimated CAGR of around 7.70%....
Colombian Women’s Health OTC & Pharma Market by 2035: Opportunities in Contraceptives, Menopause, and Intimate Care
As one of the leading pharma markets in Latin America, Colombia presents a dynamic landscape for the Women’s Health segment. With a female population of 18.3 million between the ages of 15 and 64, the market is being reshaped by a clear shift toward premium and natural products. ...
Why Italy’s Aesthetic Medicine Market is Set to Double by 2040
Italian aesthetic medicine is seeing strong momentum as Gen Z and Gen Alpha move from “repair” to prejuvenation, with an expected CAGR of 15,4% by 2040. Hyaluronic acid (HA) dermal fillers are the most common non-surgical procedures, whereas breast augmentation represents the most performed surgical procedure....
EAEU GMP Pre-Audit: How to Ensure a 99% Success Rate During Inspection?
In the rapidly evolving pharma & OTC landscape of the Eurasian Economic Union (EAEU), obtaining a Good Manufacturing Practice (GMP) certificate is no longer just a regulatory hurdle: it is a strategic gateway to a market of over 180 million people. Learn how CPC Pre-Audits & CAPA support ensure successful inspections....
EU-India Free Trade Agreement: Tariffs Down of Up To 100%. What awaits European Pharma SMEs?
India and the EU officially announced an historic Free Trade Agreement (FTA) in New Delhi. This landmark deal is set to eliminate tariffs on over 95% of trade lines, reducing duties of up to 100%, and open a rapidly growing market of 1.4 billion people. What awaits European Pharma SMEs?...
